Cargando…
Determination of cGMP levels in rodent tissues following oral dosing of a soluble guanylate cyclase stimulator
Autores principales: | Perez, Nisha, Graul, Christopher, Germano, Peter, Solberg, Erik, Rivers, Samuel, Solinga, Robert, Moore, Joel, Hannig, Gerhard, Silos-Santiago, Ada, Busby, Robert, Zimmer, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765524/ http://dx.doi.org/10.1186/2050-6511-14-S1-P54 |
Ejemplares similares
-
Linaclotide activates guanylate cyclase‐C/cGMP/protein kinase‐II‐dependent trafficking of CFTR in the intestine
por: Ahsan, Md. Kaimul, et al.
Publicado: (2017) -
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain
por: Hannig, Gerhard, et al.
Publicado: (2014) -
Metabolic fate of orally administered cGMP in rats
por: Liong, Elaine, et al.
Publicado: (2013) -
Effects of carbon monoxide-releasing molecules on cGMP levels and soluble guanylate cyclase activity
por: Marazioti, Antonia, et al.
Publicado: (2009) -
Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment
por: Barbosa Evora, Paulo Roberto
Publicado: (2018)